Indeed, discoveries of therapies for headache attributable to IIH also require systematic evaluation, as there is only one open label study investigating use of a calcitonin gene related peptide monoclonal antibody to treat headache in patients with active IIH [76]. The gene discussed is CALCA; the disease is pseudotumor cerebri.